Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov;14(5):4807-4812.
doi: 10.3892/etm.2017.5119. Epub 2017 Sep 15.

Role of miR-124a in T cell activation and immunity in AIDS patients

Affiliations

Role of miR-124a in T cell activation and immunity in AIDS patients

Wenge Zhao et al. Exp Ther Med. 2017 Nov.

Abstract

The role of microRNA-124a (miR-124a) in the regulation of T cell activation and immunity in patients with AIDS, was studied to provide new insights for the study, diagnosis, alleviation and treatment of AIDS. RT-qPCR technique was used to quantitatively analyze the expression of miR-124a in peripheral blood CD4+ T cells. Dual-luciferase reporter assay system was established to report possible regulatory relations between miR-124a and its potential target gene SIRT1. RT-qPCR and western blot analysis were used to detect the expression level of mRNA and protein of the target genes in T cells. Normal CD4+ T cells from controls were transfected with miR-124a mimics and its negative control, and miR-124a inhibitor and its negative control were transfected into CD4+ T cells from patients with AIDS by T lymphocyte transfection kit to detect the relative expression level of SIRT1 mRNA and protein. The levels of interferon (IFN)-γ, interleukin (IL)-10, transforming growth factor (TGF)-β, IL-2, IL-4 and IL-6 secreted by T helper cells were detected by enzyme-linked immunosorbent assay (ELISA). miR-124a was upregulated in CD4+ T cells of patients with AIDS. The results of firefly luciferase activity detection showed that miR-124a can directly interact with target gene SIRT1 and negatively regulate its expression. miR-124a mimics/inhibitor transfection experiments showed that overexpression of miR-124a in normal CD4+ T cells significantly reduced SIRT1 expression compared with control group, and the expression of miR-124a was positively correlated with IL-10 and TGF-β expression and negatively correlated with IFN-γ expression, but showed no correlation with other cytokines. In AIDS patients, the inhibition of expression of miR-124a in CD4+ T cells significantly increased the expression of SIRT, at the same time, the expression levels of IL-10 and TGF-β were significantly decreased, while the expression level of IFN-γ was significantly increased and no significant difference was found in the expression of other cytokines. The expression of miR-124a in CD4+ T cells of AIDS patients was upregulated and the Th2 type CD4+ T cells are activated by SIRT1 expression inhibition, which in turn enhance the immunity of HIV-infected cells. Our study provides a new molecular target for the diagnosis, alleviation and treatment of AIDS.

Keywords: AIDS; SIRT1; T cell activation; immunity; miR-124a.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The relative expression levels of miR-124a in CD4+ T cells of two groups of people. *p<0.05.
Figure 2.
Figure 2.
Luciferase relative activities after transfection with different reporter vectors and miR-124a. *p<0.05.
Figure 3.
Figure 3.
miR-124a regulates the expression of target gene SIRT1. (A) Comparison of RT-qPCR results for SIRT1 mRNA levels in CD4+ T cells of AIDS patients and healthy controls. (B) Comparison of SIRT1 protein levels in CD4+ T cells of patients and healthy people. (C) The relative expression levels of miR-124a and SIRT1 in AIDS patients. *p<0.05.
Figure 4.
Figure 4.
The effects of miR-124a overexpression on the expression levels of SIRT1 mRNA and protein and cytokine. *p<0.05.
Figure 5.
Figure 5.
The effect of miR-124a expression inhibition on the expression levels of SIRT1 mRNA and protein and related cytokine proteins. *p<0.05.

Similar articles

Cited by

References

    1. Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science. 1983;220:868–871. doi: 10.1126/science.6189183. - DOI - PubMed
    1. Klase Z, Winograd R, Davis J, Carpio L, Hildreth R, Heydarian M, Fu S, McCaffrey T, Meiri E, Ayash-Rashkovsky M, et al. HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology. 2009;6:18. doi: 10.1186/1742-4690-6-18. - DOI - PMC - PubMed
    1. Strebel K. HIV accessory proteins versus host restriction factors. Curr Opin Virol. 2013;3:692–699. doi: 10.1016/j.coviro.2013.08.004. - DOI - PMC - PubMed
    1. Weiss RA. How does HIV cause AIDS? Science. 1993;260:1273–1279. doi: 10.1126/science.8493571. - DOI - PubMed
    1. Smith-Garvin JE, Koretzky GA, Jordan MS. T cell activation. Annu Rev Immunol. 2009;27:591–619. doi: 10.1146/annurev.immunol.021908.132706. - DOI - PMC - PubMed